Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Dermatology

  Free Subscription


24.05.2021

8 Am J Dermatopathol
2 Am J Pathol
8 BMC Cancer
4 Br J Dermatol
33 Cancer
4 Cancer Res
2 Clin Exp Dermatol
10 Dermatol Online J
11 Eur J Dermatol
2 Int J Clin Pract
4 Int J Dermatol
1 Intern Med
1 J Cutan Pathol
9 J Dermatol
2 J Epidemiol
3 J Invest Dermatol
2 JAAPA
2 N Engl J Med
1 Plast Reconstr Surg
1 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Dermatopathol

  1. FREDERICO IKS, Mesbah Ardakani N, Ryan AL, Cowley MJ, et al
    Spitz Melanoma of Childhood With A Novel Promoter Hijacking Anaplastic Lymphoma Kinase (C2orf42-ALK) Rearrangement.
    Am J Dermatopathol. 2021 May 17. pii: 00000372-900000000-97738.
    PubMed         Abstract available

  2. YE CH, Chen CJ, Chang KC, Wu YH, et al
    Cutaneous Pseudolymphoma With Langerhans Cell Hyperplasia-A Rare Case With Clinical Presentation Mimicking Malignancy and Potential Diagnostic Pitfall.
    Am J Dermatopathol. 2021 May 17. pii: 00000372-900000000-97736.
    PubMed         Abstract available

  3. YI LG, Gru AA
    Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder Mimicking Jessner Lymphocytic Infiltrate and Tumid Lupus-A Report of Two Cases.
    Am J Dermatopathol. 2021 May 17. pii: 00000372-900000000-97739.
    PubMed         Abstract available

  4. LIU R, Leavens J, Smart C
    Case of Cutaneous Metastatic Prostate Carcinoma as Initial Evidence of Neuroendocrine Differentiation.
    Am J Dermatopathol. 2021 May 17. pii: 00000372-900000000-97740.
    PubMed        

  5. RONEN S, Suster D, Chen WS, Ronen N, et al
    Histologic Patterns of Cutaneous Metastases of Breast Carcinoma: A Clinicopathologic Study of 232 Cases.
    Am J Dermatopathol. 2021;43:401-411.
    PubMed         Abstract available

  6. ROZAS-MUNOZ E, Campos MC, Roe E, Mir-Bonafe JF, et al
    Multiple Dermatofibroma-Like Lesions in a 37-Year-Old Man: Answer.
    Am J Dermatopathol. 2021;43:464-465.
    PubMed        

  7. ROZAS-MUNOZ E, Campos MC, Roe E, Mir-Bonafe JF, et al
    Multiple Dermatofibroma-Like Lesions in a 37-Year-Old Man: Challenge.
    Am J Dermatopathol. 2021;43:e72-e73.
    PubMed        

  8. BAKER LX, Grilletta E, Zwerner JP, Boyd AS, et al
    Clinical and Histopathologic Characteristics of Metastatic and Locally Advanced Cutaneous Basal Cell Carcinomas.
    Am J Dermatopathol. 2021 May 17. pii: 00000372-900000000-97737.
    PubMed         Abstract available


    Am J Pathol

  9. ANWAR T, Gonzalez ME, Kleer CG
    Non-canonical functions of the Polycomb group protein EZH2 in breast cancer.
    Am J Pathol. 2021 Feb 5. pii: S0002-9440(21)00044.
    PubMed         Abstract available

  10. MEYER JM, Crumrine D, Schneider H, Dick A, et al
    Unbound Corneocyte Lipid Envelopes in 12R-Lipoxygenase Deficiency Support a Specific Role in Lipid-Protein Cross-Linking.
    Am J Pathol. 2021;191:921-929.
    PubMed         Abstract available


    BMC Cancer

  11. TSUJI K, Matsuoka YJ, Ochi E
    High-intensity interval training in breast cancer survivors: a systematic review.
    BMC Cancer. 2021;21:184.
    PubMed         Abstract available

  12. AREFAN D, Hausler RM, Sumkin JH, Sun M, et al
    Predicting cell invasion in breast tumor microenvironment from radiological imaging phenotypes.
    BMC Cancer. 2021;21:370.
    PubMed         Abstract available

  13. BERGER K, Rhost S, Rafnsdottir S, Hughes E, et al
    Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer.
    BMC Cancer. 2021;21:185.
    PubMed         Abstract available

  14. LIANG G, Ma W, Zhao Y, Liu E, et al
    Risk factors for pegylated liposomal doxorubicin-induced moderate to severe hand-foot syndrome in breast cancer patients: assessment of baseline clinical parameters.
    BMC Cancer. 2021;21:362.
    PubMed         Abstract available

  15. LIU Z, Liu J, Liu R, Xue M, et al
    Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification.
    BMC Cancer. 2021;21:367.
    PubMed         Abstract available

  16. REECE JC, Neal EFG, Nguyen P, McIntosh JG, et al
    Delayed or failure to follow-up abnormal breast cancer screening mammograms in primary care: a systematic review.
    BMC Cancer. 2021;21:373.
    PubMed         Abstract available

  17. COLOMBIE M, Jezequel P, Rubeaux M, Frenel JS, et al
    The EPICURE study: a pilot prospective cohort study of heterogeneous and massive data integration in metastatic breast cancer patients.
    BMC Cancer. 2021;21:333.
    PubMed         Abstract available

  18. CHEN S, Han Y, Ouyang Q, Lu J, et al
    Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy.
    BMC Cancer. 2021;21:341.
    PubMed         Abstract available


    Br J Dermatol

  19. QUEIROS C, Silva L, Miroux Catarino A, Labareda J, et al
    Topical imiquimod as neoadjuvant therapy before Mohs micrographic surgery for basal cell carcinoma in the head and neck region: findings from a large retrospective study.
    Br J Dermatol. 2021 May 16. doi: 10.1111/bjd.20487.
    PubMed         Abstract available

  20. KHURANA A, Mittal A, Jain R, Mishra A, et al
    Rarity of cutaneous findings among asymptomatic to mildly symptomatic COVID-19 patients admitted to a COVID Care facility in Delhi, India: An observational study.
    Br J Dermatol. 2021 May 16. doi: 10.1111/bjd.20488.
    PubMed         Abstract available

  21. ROSELEUR J, Gonzalez-Chica DA, Emery J, Stocks NP, et al
    Skin checks and skin cancer diagnosis in Australian general practice before and during the COVID pandemic, 2011-2020.
    Br J Dermatol. 2021 May 19. doi: 10.1111/bjd.20494.
    PubMed         Abstract available

  22. JONAK C, Alkon N, Rindler K, Rojahn TB, et al
    Single-cell RNAseq profiling in a patient with discordant primary cutaneous B and T cell lymphoma reveals micromilieu-driven immune skewing.
    Br J Dermatol. 2021 May 21. doi: 10.1111/bjd.20512.
    PubMed         Abstract available


    Cancer

  23. MA D, Jiang YZ, Xiao Y, Xie MD, et al
    Integrated molecular profiling of young and elderly patients with triple-negative breast cancer indicates different biological bases and clinical management strategies.
    Cancer. 2020 May 8. doi: 10.1002/cncr.32922.
    PubMed         Abstract available

  24. BROWN LC, Murphy AR, Lalonde CS, Subhedar PD, et al
    Posttraumatic stress disorder and breast cancer: Risk factors and the role of inflammation and endocrine function.
    Cancer. 2020 May 6. doi: 10.1002/cncr.32934.
    PubMed         Abstract available

  25. ROSITCH AF, Unger-Saldana K, DeBoer RJ, Ng'ang'a A, et al
    The role of dissemination and implementation science in global breast cancer control programs: Frameworks, methods, and examples.
    Cancer. 2020;126 Suppl 10:2394-2404.
    PubMed         Abstract available

  26. MUTEBI M, Anderson BO, Duggan C, Adebamowo C, et al
    Breast cancer treatment: A phased approach to implementation.
    Cancer. 2020;126 Suppl 10:2365-2378.
    PubMed         Abstract available

  27. DVALADZE A, Kizub DA, Cabanes A, Nakigudde G, et al
    Breast cancer patient advocacy: A qualitative study of the challenges and opportunities for civil society organizations in low-income and middle-income countries.
    Cancer. 2020;126 Suppl 10:2439-2447.
    PubMed         Abstract available

  28. HORTON S, Camacho Rodriguez R, Anderson BO, Aung S, et al
    Health system strengthening: Integration of breast cancer care for improved outcomes.
    Cancer. 2020;126 Suppl 10:2353-2364.
    PubMed         Abstract available

  29. GINSBURG O, Yip CH, Brooks A, Cabanes A, et al
    Breast cancer early detection: A phased approach to implementation.
    Cancer. 2020;126 Suppl 10:2379-2393.
    PubMed         Abstract available

  30. HENDERSON V, Tossas-Milligan K, Martinez E, Williams B, et al
    Implementation of an integrated framework for a breast cancer screening and navigation program for women from underresourced communities.
    Cancer. 2020;126 Suppl 10:2481-2493.
    PubMed         Abstract available

  31. SCHEEL JR, Giglou MJ, Segel S, Orem J, et al
    Breast cancer early detection and diagnostic capacity in Uganda.
    Cancer. 2020;126 Suppl 10:2469-2480.
    PubMed         Abstract available

  32. DVALADZE A, Duggan C, Anderson BO
    Phased implementation for breast cancer management in low-income and middle-income countries: A proposal for the strategic application of resource-stratified guidelines by the Breast Health Global Initiative.
    Cancer. 2020;126 Suppl 10:2337-2338.
    PubMed        

  33. ZHOU J, Wang H, Fu F, Li Z, et al
    Spectrum of PALB2 germline mutations and characteristics of PALB2-related breast cancer: Screening of 16,501 unselected patients with breast cancer and 5890 controls by next-generation sequencing.
    Cancer. 2020 Apr 27. doi: 10.1002/cncr.32905.
    PubMed         Abstract available

  34. NYROP KA, Deal AM, Reeve BB, Basch E, et al
    Congruence of patient- and clinician-reported toxicity in women receiving chemotherapy for early breast cancer.
    Cancer. 2020 Apr 21. doi: 10.1002/cncr.32898.
    PubMed         Abstract available

  35. REIS JC, Travado L, Antoni MH, Oliveira FPM, et al
    Negative affect and stress-related brain metabolism in patients with metastatic breast cancer.
    Cancer. 2020 Apr 14. doi: 10.1002/cncr.32902.
    PubMed         Abstract available

  36. CONTE P, Schneeweiss A, Loibl S, Mamounas EP, et al
    Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer.
    Cancer. 2020 Apr 14. doi: 10.1002/cncr.32873.
    PubMed         Abstract available

  37. FARVID MS, Spence ND, Holmes MD, Barnett JB, et al
    Fiber consumption and breast cancer incidence: A systematic review and meta-analysis of prospective studies.
    Cancer. 2020 Apr 6. doi: 10.1002/cncr.32816.
    PubMed         Abstract available

  38. ARORA M, Chen Y, Hageman L, Wu J, et al
    Morbidity burden in survivors of multiple myeloma who underwent autologous transplantation: A Bone Marrow Transplantation Survivor Study.
    Cancer. 2020 May 15. doi: 10.1002/cncr.32941.
    PubMed         Abstract available

  39. SHARIFI MN, Anandan A, Grogan P, O'Regan RM, et al
    Therapy after cyclin-dependent kinase inhibition in metastatic hormone receptor-positive breast cancer: Resistance mechanisms and novel treatment strategies.
    Cancer. 2020 May 19. doi: 10.1002/cncr.32931.
    PubMed         Abstract available

  40. CACHO-DIAZ B, Salmeron-Moreno K, Alvarez-Alvarez A, Mendoza-Olivas LG, et al
    Identification of risk factors for central nervous system metastasis in patients with breast cancer with neurologic symptoms.
    Cancer. 2020 May 26. doi: 10.1002/cncr.32928.
    PubMed         Abstract available

  41. PRINTZ C
    Early breast cancer screening in childhood cancer survivors treated with chest radiation may reduce deaths by more than 50.
    Cancer. 2020;126:5197.
    PubMed        

  42. MARMOR S, Longacre CF, Altman AM, Hui JYC, et al
    Genomic expression assay testing among American Indian and Alaska Native women with breast cancer.
    Cancer. 2020 Sep 14. doi: 10.1002/cncr.33150.
    PubMed         Abstract available

  43. AN X, Lei X, Huang R, Luo R, et al
    Adjuvant chemotherapy for small, lymph node-negative, triple-negative breast cancer: A single-center study and a meta-analysis of the published literature.
    Cancer. 2020;126 Suppl 16:3837-3846.
    PubMed         Abstract available

  44. YANG H, Zhang S, Liu P, Cheng L, et al
    Use of high-resolution full-field optical coherence tomography and dynamic cell imaging for rapid intraoperative diagnosis during breast cancer surgery.
    Cancer. 2020;126 Suppl 16:3847-3856.
    PubMed         Abstract available

  45. GUO R, Su Y, Si J, Xue J, et al
    A nomogram for predicting axillary pathologic complete response in hormone receptor-positive breast cancer with cytologically proven axillary lymph node metastases.
    Cancer. 2020;126 Suppl 16:3819-3829.
    PubMed         Abstract available

  46. TANG Y, Zhang YJ, Zhang N, Shi M, et al
    Nomogram predicting survival as a selection criterion for postmastectomy radiotherapy in patients with T1 to T2 breast cancer with 1 to 3 positive lymph nodes.
    Cancer. 2020;126 Suppl 16:3857-3866.
    PubMed         Abstract available

  47. PAN H, Zhang K, Wang M, Ling L, et al
    The effect of chemotherapy on survival in patients with nonmetastatic male breast cancer: A population-based observational study.
    Cancer. 2020;126 Suppl 16:3830-3836.
    PubMed         Abstract available

  48. XU B, Hu X, Feng J, Geng C, et al
    Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018).
    Cancer. 2020;126 Suppl 16:3867-3882.
    PubMed         Abstract available

  49. FAN Y, Xu B
    Current clinical trials on breast cancer in China: A systematic literature review.
    Cancer. 2020;126 Suppl 16:3811-3818.
    PubMed         Abstract available

  50. SHEPPARD VB, Dash C, Nomura S, Sutton AL, et al
    Physical activity, health-related quality of life, and adjuvant endocrine therapy-related symptoms in women with hormone receptor-positive breast cancer.
    Cancer. 2020 Jul 2. doi: 10.1002/cncr.33054.
    PubMed         Abstract available

  51. SUAREZ-ALMAZOR ME, Herrera R, Lei X, Chavez-MacGregor M, et al
    Survival in older women with early stage breast cancer receiving low-dose bisphosphonates or denosumab.
    Cancer. 2020 Jun 23. doi: 10.1002/cncr.33035.
    PubMed         Abstract available

  52. PAN K, Chlebowski RT, Mortimer JE, Gunther MJ, et al
    Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women's Health Initiative.
    Cancer. 2020 Jun 12. doi: 10.1002/cncr.33002.
    PubMed         Abstract available

  53. IBRAHEEM A, Olopade OI, Huo D
    Propensity score analysis of the prognostic value of genomic assays for breast cancer in diverse populations using the National Cancer Data Base.
    Cancer. 2020 Jun 10. doi: 10.1002/cncr.32956.
    PubMed         Abstract available

  54. DANCIU OC, Chen Z, Hoskins KF
    If you don't measure it, you can't improve it: Success and shortcomings of genomic assays in early breast cancer.
    Cancer. 2020 Jun 10. doi: 10.1002/cncr.32955.
    PubMed        

  55. MA S, Shepard DS, Ritter GA, Martell RE, et al
    The impact of the introduction of generic aromatase inhibitors on adherence to hormonal therapy over the full course of 5-year treatment for breast cancer.
    Cancer. 2020 Jun 2. doi: 10.1002/cncr.32976.
    PubMed         Abstract available


    Cancer Res

  56. KUMARASAMY V, Vail P, Nambiar R, Witkiewicz AK, et al
    Functional Determinants of Cell Cycle Plasticity and Sensitivity to CDK4/6 Inhibition.
    Cancer Res. 2021;81:1347-1360.
    PubMed         Abstract available

  57. DAI M, Boudreault J, Wang N, Poulet S, et al
    Differential Regulation of Cancer Progression by CDK4/6 Plays a Central Role in DNA Replication and Repair Pathways.
    Cancer Res. 2021;81:1332-1346.
    PubMed         Abstract available

  58. LIU Z, Sun L, Cai Y, Shen S, et al
    Hypoxia-induced suppression of alternative splicing of MBD2 promotes breast cancer metastasis via activation of FZD1.
    Cancer Res. 2021 Jan 5. pii: 0008-5472.CAN-20-2876.
    PubMed         Abstract available

  59. MILLER KD, Pniewski K, Perry CE, Papp SB, et al
    Targeting ACSS2 with a transition state mimetic inhibits triple-negative breast cancer growth.
    Cancer Res. 2021 Jan 7. pii: 0008-5472.CAN-20-1847.
    PubMed         Abstract available


    Clin Exp Dermatol

  60. REGAN H, Marren P
    Melanoma and Li-Fraumeni syndrome - family history not essential for screening recommendation.
    Clin Exp Dermatol. 2021 May 19. doi: 10.1111/ced.14748.
    PubMed         Abstract available

  61. NOZAWA Y, Nakamura Y, Ono N, Hirai I, et al
    A well-defined, firm, yellowish-orange alopecic plaque with multiple whitish papules on the scalp.
    Clin Exp Dermatol. 2021 May 18. doi: 10.1111/ced.14663.
    PubMed        


    Dermatol Online J

  62. BELL KA, Pourang A, Mesinkovska NA, Cardis MA, et al
    The effect of gluten on skin and hair: a systematic review.
    Dermatol Online J. 2021;27.
    PubMed         Abstract available

  63. DRUGGE ED, Sarac RM, Fay P, Drugge RJ, et al
    Semi-automated total body photography supports robust delivery of skin cancer monitoring services during the SARS-COV2/COVID-19 pandemic.
    Dermatol Online J. 2021;27.
    PubMed         Abstract available

  64. YOUNG PA, Bae GH, Konia TH
    Subcorneal pustular dermatosis associated with IgG monoclonal gammopathy of undetermined significance.
    Dermatol Online J. 2021;27.
    PubMed         Abstract available

  65. KENNEDY AM, Muhaj FF, Tschen JA, Silapunt S, et al
    Linear lichen planus pigmentosus of the face with histological findings of lichen planopilaris - an uncommon variant of lichen planus.
    Dermatol Online J. 2021;27.
    PubMed         Abstract available

  66. ULMER K, Powers J, Alrwashdeh A, Hardy-Fairbanks A, et al
    Metastatic malignant melanoma in an endometrial polyp.
    Dermatol Online J. 2021;27.
    PubMed         Abstract available

  67. HENCKENS N, Rovers J, Van Dommelen L, Bovenschen HJ, et al
    Can cats cause colossal contagious cutaneous carbuncles?
    Dermatol Online J. 2021;27.
    PubMed         Abstract available

  68. BETZ J, Grover RK, Ullman L
    Evaluation of IgA epidermal transglutaminase ELISA in suspected dermatitis herpetiformis patients.
    Dermatol Online J. 2021;27.
    PubMed        

  69. CHANG MS, Leachman SA, Berry EG, Curiel-Lewandrowski C, et al
    Changes in melanoma care practices during the COVID-19 pandemic: a multi-institutional cross-sectional survey.
    Dermatol Online J. 2021;27.
    PubMed        

  70. HUANG C, Chen T
    SARS-CoV-2 infection in a patient with psoriasis treated with risankizumab.
    Dermatol Online J. 2021;27.
    PubMed        

  71. DANSET M, Lesort C, Jullien D, Kanitakis J, et al
    Cutaneous calciphylaxis of the glans penis presenting as a gangrenous ulceration.
    Dermatol Online J. 2021;27.
    PubMed        


    Eur J Dermatol

  72. LEDUCQ S, Gabeff R, Zaragoza J, Poiraud C, et al
    Topical sirolimus 1% for benign lymphangiomatous papules after radiotherapy for endometrial and breast cancers: a report of three cases.
    Eur J Dermatol. 2021;31:252-254.
    PubMed        

  73. ESPINOSA-RUEDA MI, Montero-Vilchez T, Martinez-Lopez A, Molina-Leyva A, et al
    Cutaneous homeostasis and epidermal barrier function in a young healthy Caucasian population.
    Eur J Dermatol. 2021;31:176-182.
    PubMed         Abstract available

  74. SALIBA M, Shaheen M, El Hajj R, Abbas FI, et al
    Sebaceous neoplasms: prevalence of HPV infection and relation to immunohistochemical surrogate markers.
    Eur J Dermatol. 2021;31:170-175.
    PubMed         Abstract available

  75. NOSBAUM A, Dahel K, Goujon C, Nicolas JF, et al
    Psoriasis is a disease of the entire skin: non-lesional skin displays a prepsoriasis phenotype.
    Eur J Dermatol. 2021;31:143-154.
    PubMed         Abstract available

  76. THEODOSIOU G, Belfrage E, Berggard K, Cristiansen J, et al
    Infantile transient smooth muscle contraction of the skin: a case report and literature review.
    Eur J Dermatol. 2021;31:260-261.
    PubMed        

  77. GAMBICHLER T, Brown V, Siebold A, Stucker M, et al
    Disseminated classic Kaposi sarcoma in a seven-year-old girl.
    Eur J Dermatol. 2021;31:269-270.
    PubMed        

  78. VERLINDEN L, Speeckaert R, Van Laecke S, Lapeere H, et al
    Trichodysplasia spinulosa, a challenging skin disorder successfully treated with camellia sinensis 10% ointment.
    Eur J Dermatol. 2021;31:272-273.
    PubMed        

  79. JOVIC A, Tiodorovic D, Popovic D, Vidovic N, et al
    Multiple eruptive squamous cell carcinomas: a possible clinical sign in melanoma patients treated with vemurafenib.
    Eur J Dermatol. 2021;31:279-280.
    PubMed        

  80. MOHME S, Goebeler M, Hamm H
    A child with blistering skin lesions: a crown of jewels.
    Eur J Dermatol. 2021;31:285-286.
    PubMed        

  81. HAMOUDA MB, Krifa M, Gammoudi R
    sQuiz your knowledge: Reddish-yellow papules on axillary and inguinal folds.
    Eur J Dermatol. 2021;31:292-294.
    PubMed        

  82. SANCHEZ-MARTINEZ EM, Melgosa-Ramos FJ, Marti-Ibor E
    sQUIZ your knowledge! Sudden onset of protuberant papules in a girl.
    Eur J Dermatol. 2021;31:295-297.
    PubMed        


    Int J Clin Pract

  83. OZTURK M, An I
    Do blood groups play a role in the aetiology of chronic urticaria?
    Int J Clin Pract. 2021;75:e13884.
    PubMed        

  84. ODLER B, Hebesberger C, Hoeflechner L, Pregartner G, et al
    Effect of short-interval rituximab and high-dose corticosteroids on kidney function in systemic sclerosis: Long-term experience of a single centre.
    Int J Clin Pract. 2021;75:e14069.
    PubMed         Abstract available


    Int J Dermatol

  85. ORIZAGA-Y-QUIROGA TL, Ocampo-Garza SS, Olvera-Rodriguez V, Herz-Ruelas ME, et al
    Two new cases of testicular choriocarcinoma with cutaneous metastases.
    Int J Dermatol. 2021 May 17. doi: 10.1111/ijd.15666.
    PubMed        

  86. WINDER G, Kawar M, Shalom A
    Anatomical distribution of basal cell carcinoma in Israel using relative tumor density scores.
    Int J Dermatol. 2021 May 20. doi: 10.1111/ijd.15577.
    PubMed         Abstract available

  87. OZKOK AKBULUT T, Topaloglu Demir F, Oguz Topal I, Kara Polat A, et al
    Drug survival and predictor factors for discontinuation of methotrexate in psoriasis: a real-life multicenter study.
    Int J Dermatol. 2021 May 20. doi: 10.1111/ijd.15628.
    PubMed         Abstract available

  88. CERCI FB, Kubo EM, Werner B, Tolkachjov SN, et al
    Dermoscopy accuracy for lateral margin assessment of distinct basal cell carcinoma subtypes treated by Mohs micrographic surgery in 368 cases.
    Int J Dermatol. 2021 May 20. doi: 10.1111/ijd.15655.
    PubMed        


    Intern Med

  89. HANIOKA Y, Shimizu K, Yamagami K, Yao S, et al
    Exacerbation of Ulcerative Colitis with Tocilizumab: A Report of Two Cases, One with Takayasu Arteritis and the Other with Relapsing Polychondritis.
    Intern Med. 2021;60:1615-1620.
    PubMed         Abstract available


    J Cutan Pathol

  90. TABB ES, Duncan LM, Nazarian RM
    Eosinophilic Granulomatosis with Polyangiitis: Cutaneous Clinical and Histopathologic Differential Diagnosis.
    J Cutan Pathol. 2021 May 21. doi: 10.1111/cup.14065.
    PubMed        


    J Dermatol

  91. PIZZICHETTA MA, Canzonieri V, Rubegni P, Corneli P, et al
    Tips for difficult to diagnose hypomelanotic melanomas on reflectance confocal microscopy.
    J Dermatol. 2021 May 17. doi: 10.1111/1346-8138.15815.
    PubMed         Abstract available

  92. OKUMA T, Furudate S, Kambayashi Y, Hashimoto A, et al
    Successful treatment of BRAF/MEK inhibitor-resistant advanced cutaneous melanoma with nivolumab plus ipilimumab combination therapy followed by intensity-modulated radiotherapy.
    J Dermatol. 2021 May 18. doi: 10.1111/1346-8138.15962.
    PubMed         Abstract available

  93. TAKAMURA S, Teraki Y
    Interleukin (IL)-13/IL-22/IL-31 skewing within the skin-homing T-cell population in papuloerythroderma.
    J Dermatol. 2021 May 18. doi: 10.1111/1346-8138.15937.
    PubMed         Abstract available

  94. YASUDA M, Morimoto N, Inoue Y, Ishikawa O, et al
    Clinical course and background of eight patients who discontinued secukinumab after achieving a score of 0 on the psoriasis area and severity index.
    J Dermatol. 2021 May 18. doi: 10.1111/1346-8138.15948.
    PubMed        

  95. OBA J, Woodman SE
    The genetic and epigenetic basis of distinct melanoma types.
    J Dermatol. 2021 May 18. doi: 10.1111/1346-8138.15957.
    PubMed         Abstract available

  96. BOSMA AL, Ouwerkerk W, Gunal M, Hyseni AM, et al
    Work ability and quality of working life in atopic dermatitis patients treated with dupilumab.
    J Dermatol. 2021 May 19. doi: 10.1111/1346-8138.15939.
    PubMed         Abstract available

  97. ZHENG J, Chen W, Gao Y, Chen F, et al
    Clinical analysis of generalized pustular psoriasis in Chinese patients: A retrospective study of 110 patients.
    J Dermatol. 2021 May 21. doi: 10.1111/1346-8138.15958.
    PubMed         Abstract available

  98. ISHIGURO A, Ogata D, Namikawa K, Takahashi A, et al
    Two cases of advanced cutaneous squamous cell carcinoma lesions on the head and neck successfully treated with nivolumab.
    J Dermatol. 2021 May 21. doi: 10.1111/1346-8138.15971.
    PubMed        

  99. FUKUSHIMA H, Iwata Y, Saito K, Sugiura K, et al
    Successful rechallenge therapy for BRAF/MEK inhibitor-resistant multiple brain metastases of melanoma.
    J Dermatol. 2021 May 21. doi: 10.1111/1346-8138.15969.
    PubMed         Abstract available


    J Epidemiol

  100. OBA MS, Murakami Y, Nishiwaki Y, Asakura K, et al
    Estimated Prevalence of Cronkhite-Canada Syndrome, Chronic Enteropathy Associated With SLCO2A1 Gene, and Intestinal Behcet's Disease in Japan in 2017: A Nationwide Survey.
    J Epidemiol. 2021;31:139-144.
    PubMed         Abstract available

  101. KITANO N, Takeuchi T, Suenaga T, Kakimoto N, et al
    Seasonal Variation in Epidemiology of Kawasaki Disease-Related Coronary Artery Abnormalities in Japan, 1999-2017.
    J Epidemiol. 2021;31:132-138.
    PubMed         Abstract available


    J Invest Dermatol

  102. MICHIELS C, Puigdevall L, Cochez P, Achouri Y, et al
    A targetable, non-canonical STAT3 activation induced by the tyrosine-less region of IL-22R orchestrates imiquimod-induced psoriasis-like dermatitis in mice.
    J Invest Dermatol. 2021 May 13. pii: S0022-202X(21)01227.
    PubMed         Abstract available

  103. TSENG YJ, Lee CH, Chen WY, Yang JL, et al
    Inhibition of plasminogen activator inhibitor-1 blocks programmed death ligand 1 endocytosis and improves the response of melanoma cells to immune checkpoint blockade.
    J Invest Dermatol. 2021 May 14. pii: S0022-202X(21)01230.
    PubMed         Abstract available

  104. LIN Y, Xue K, Li Q, Liu Z, et al
    Cyclin-Dependent Kinase 7 Promotes Th17/Th1 Cell Differentiation in Psoriasis by Modulating Glycolytic Metabolism.
    J Invest Dermatol. 2021 May 15. pii: S0022-202X(21)01232.
    PubMed         Abstract available


    JAAPA

  105. MILLARD N
    A rare disorder causing chronic joint pain in an adolescent.
    JAAPA. 2021;34:32-34.
    PubMed         Abstract available

  106. ROBINSON K, Zerfoss C, Nicholas J, Rolfs J, et al
    Brain metastasis in a patient with multiple malignancies.
    JAAPA. 2021;34:28-31.
    PubMed         Abstract available


    N Engl J Med

  107. PUERTA-PENA M, Velasco-Tamariz V
    Herpes-Associated Erythema Multiforme.
    N Engl J Med. 2021;384:1848.
    PubMed        

  108. MOHAMED F, Raal FJ
    Hyperpigmentation from Addison's Disease.
    N Engl J Med. 2021;384:1752.
    PubMed        


    Plast Reconstr Surg

  109. ABDELHAKIM M, Dohi T, Yamato M, Takada H, et al
    A New Model for Specific Visualization of Skin Graft Neoangiogenesis Using Flt1-tdsRed BAC Transgenic Mice.
    Plast Reconstr Surg. 2021 May 20. pii: 00006534-990000000-00170.
    PubMed         Abstract available


    PLoS One

  110. RASTOGI A, Hiteshi P, Bhansali A A, Jude EB, et al
    Virtual triage and outcomes of diabetic foot complications during Covid-19 pandemic: A retro-prospective, observational cohort study.
    PLoS One. 2021;16:e0251143.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  111. DAMAGHI M, West J, Robertson-Tessi M, Xu L, et al
    The harsh microenvironment in early breast cancer selects for a Warburg phenotype.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: